Aims-To examine the relation between invasive adenocarcinoma and its alleged precursor, cervical glandular intraepithelial neoplasia (CGIN), and to assess the management and outcome of CGIN and the validity of using the term "microinvasive adenocarcinoma." Methods-The clinical and pathological features of 121 cases of glandular neoplasia of the cervix diagnosed between the years 1990 to 1995 were examined for the following: histological diagnosis, smear records, type of treatment, the association between the precursor lesions and invasive disease, and follow up. 1999;52:112-117) 
In the last few decades adenocarcinomas have formed an increasing proportion of cervical neoplasms. This proportion has risen from 5% in the 1950s to 10-22% in the mid-1990s. [1] [2] [3] [4] With this increase, more precursor lesions are being seen. The latter fall into a morphological spectrum ranging from mild to severe abnormalities, best referred to as cervical glandular intraepithelial neoplasia (CGIN). [5] [6] [7] Unlike its squamous counterpart (cervical intraepithelial neoplasia, CIN, as used in the United Kingdom), CGIN has been divided into low grade lesions (glandular dysplasia; L-CGIN) and high grade lesions (adenocarcinoma in situ, H-CGIN). [8] [9] [10] [11] [12] [13] [14] [15] This is more akin to the Bethesda classification of squamous intraepithelial lesions (SIL).
Information regarding incidence, natural history, and the relation between the alleged precursor lesions and invasive adenocarcinoma has been limited. A few studies have shown that women with H-CGIN are 10 to 20 years younger than those with invasive disease 14 16 and that invasive adenocarcinoma and CGIN commonly coexist in the same specimen. 17 18 The natural history of L-CGIN is even less clear. Brown and Wells 8 have found that progression from low to high grade lesion could take place in 1.5 to 3 years. It has also been suggested that women with L-CGIN are at increased risk of further preinvasive glandular changes in the genital tract. [19] [20] [21] Another diYculty concerning glandular neoplasia of the cervix is the controversial terminology of microinvasive adenocarcinoma, its natural history, and its histological recognition. 6 22 23 The few reports that have recently appeared regarding microinvasive adenocarcinoma have defined the tumour as invading up to 5 mm from the surface of the lesion and to have an excellent prognosis, similar to its squamous counterpart. 6 22-27 The first sign of stromal invasion is identified when H-CGIN shows an abrupt glandular change, the cells becoming enlarged with abundant eosinophilic, squamoid-like cytoplasm. 22 23 28 This appearance corresponds to stage 1A1 of the 1986 International Federation of Gynecology and Obstetrics (FIGO) definition. 29 More advanced invasive changes become measurable in two or three dimensions, corresponding to the 1986 FIGO stage 1A2. In this case the gland usually develops a marked cribriform pattern and appears more crowded and neoplastic, often with a clear stromal response extending beyond the normal crypt field. It may also show a solid or papillary growth pattern, but within a depth of 5 mm. 23 However, there is very little information on the incidence of microinvasive adenocarcinoma and its relation to H-CIGN. 25 Although the cytological features of CGIN have been established, 6 11 15 30 the diagnostic sensitivity of the cervical smear test is still less than for its squamous counterpart. This is especially so in the presence of a coexisting squamous lesion. 8 9 31 Finally there is an ongoing problem in management of CGIN and microinvasive adenocarcinoma. High grade CGIN has been variously treated by hysterectomy or cone excision of the cervix. 5 6 9 32 33 Residual disease following cold knife conisation with negative margins for adenocarcinoma in situ has been also reported. 5 32 33 Microinvasive adenocarcinoma has been successfully treated by cold conisation or hysterectomy, like its squamous counterpart. 23 25 However, pelvic recurrence following radical hysterectomy has been documented. 25 In our department we receive approximately 90 000 cervical smears and 2500 to 3000 cervical loop excisions annually. We have been encountering glandular neoplasms of the uterine cervix with increasing frequency. The aim of this study was to carry out a retrospective review of the experience of the pathology department, Edinburgh University, with respect to these lesions. In particular, we wished to address the unresolved question of the relation between invasive adenocarcinoma and its alleged precursor lesions, to assess the management and outcome of CGIN, and to consider the validity of the use of the term "microinvasive adenocarcinoma."
Methods

PATHOLOGICAL ASSESSMENT
The computerised files of the pathology department, Edinburgh University, were searched from January 1990 to December 1995 to identify all cases diagnosed with glandular dysplasia, adenocarcinoma in situ, and invasive adenocarcinoma. The reviewed material included diathermy loop excisions of the uterine cervix and hysterectomy specimens. These were Bouin or formalin fixed, and the cervices were circumferentially cut into 8-17 blocks. The sections were stained with haematoxylin and eosin (H&E). These were reviewed for the presence of low and high grade CGIN, evidence of early or frank invasion, and any associated CIN. The lesions were considered multifocal if they aVected diVerent sites along the endocervical canal or if they were separated by at least 3 mm of normal endocervical epithelium.
The histological criteria used were based on those previously described. according to the criterion mentioned abovethat is, invasion of the stroma to 5 mm or less. This was measured from the nearest piece of abnormal glandular epithelium lining either the cervical canal or an endocervical gland. The depth of invasion was measured using a calibrated ocular micrometer.
FRANKLY INVASIVE ADENOCARCINOMA
The diagnosis of frankly invasive adenocarcinoma was based on morphological grounds without the use of any special stains. Adenosquamous carcinomas were excluded for the purpose of the study.
SMEAR HISTORY
The smear histories of all women were obtained from our departmental computer records. These included at least two preceding smears and two to seven follow up smears.
CLINICAL DATA
The age of the patients, methods of treatment, and the presence or absence of residual disease were obtained from our departmental records.
Results
Clinical details of the patients are given in table 1. There were 121 patients with glandular neoplasia of the cervix. Twenty seven were L-CGIN, 38 H-CGIN, 10 microinvasive, and 46 had invasive adenocarcinoma.
Eight of the microinvasive cases were FIGO stage 1A1 (less than 3 mm depth), with an average depth of 2.76 mm, and two were stage 1A2 (depth of 3-5 mm), with an average of 4.2 mm.
The mean age of the patients increased from 39 years for L-CGIN (range 26 to 67 years), to 43 years for both H-CGIN and microinvasive adenocarcinoma (range 22 to 77 years and 33 to 60 years, respectively), to 48 years for invasive adenocarcinoma (range 34 to 75 years).
Cervical smears were taken before diagnosis in 70% of L-CGIN cases (19 of 27), 76% of H-CGIN cases (29 of 38) , and in all 10 cases of microinvasive carcinoma. Among these, glandular abnormality was predicted in 59% of L-CGIN cases (eight glandular abnormality and three mixed lesion), 70% of H-CGIN cases (15 glandular abnormality and five mixed lesion), and 100% of microinvasive adenocarcinoma cases. The remaining smears predicted squamous abnormality only.
Thirty per cent of L-CGIN cases and 24% of H-CGIN cases were discovered incidentally at loop excision for CIN or at hysterectomy for benign lesions. Of the invasive adenocarcinomas, 55% were symptomatic, 32% were screen detected, 7% were discovered at loop excision for squamous dyskaryosis, and 6% were beyond the screening age group of 65 years. Twenty eight percent of L-CGIN cases and 26% of H-CGIN cases were multifocal.
The association between precursor lesions and invasive disease is seen in table 2. High grade CGIN was seen in all cases of microinvasive adenocarcinoma (95% confidence interval (CI) 69% to 100%) and in 26% of invasive disease (95% CI 13% to 40%). Low grade CGIN was seen in 13% of cases of H-CGIN (95% CI 3% to 28%) and in 18% of cases of microinvasive adenocarcinoma (95% CI 2% to 52%).
Associated CIN was found in 16 of 29 cases of L-CGIN (55%), 18 of 38 cases of H-CIGN (47%), four of 10 cases of microinvasion, and five of 48 cases of invasive adenocarcinoma (11%).
Twenty of 27 cases of L-CGIN (74%), 20 of 38 cases of H-CGIN (52%), and one of 10 cases of microinvasive adenocarcinoma were treated by diathermy loop excision of cervix only, and the remaining cases were treated by hysterectomy. Seventy one per cent of cases of invasive adenocarcinoma were treated by hysterectomy, with or without radiotherapy, and the remaining cases were treated by radiotherapy alone.
Residual disease was present in 43%, 50%, 33%, and 73% of hysterectomies for L-CGIN, H-CGIN, microinvasive adenocarcinoma, and invasive adenocarcinoma, respectively. This correlated with positive margins, or disease within 3 mm of margins on loop specimens. Only one case of H-CGIN with negative margins on loop excision showed residual disease on hysterectomy.
Follow up for two to seven years by cervical smears (number of smears ranging from four to nine) showed subsequent glandular abnormality in 10% of high grade lesions treated by loop excision only. No glandular recurrence was seen in any of the microinvasive adenocarcinomas. However, 90% of these cases were treated by hysterectomy. In addition, 17% of surviving women with invasive adenocarcinoma showed glandular abnormalities on cervical smear. Smears suggesting CIN were found in 15% of L-CGIN and 2% H-CGIN cases; normal results were reported in the remainder.
Discussion
Our study supports the view that CGIN is a precursor of invasive adenocarcinoma. 6 14 16 21 The mean age of women progressively increased from 39 years for L-CGIN, to 43 years for both H-CGIN and microinvasive adenocarcinoma, and 48 years for adenocarcinoma, a span of approximately 10 years. The diVerence in mean age, however, between H-CGIN and frankly invasive disease was only five years. This concurs with previous studies showing CGIN preceding invasive adenocarcinoma by an interval ranging from two to eight years. 14 17 18 Other studies have shown that women with H-CGIN are 10 to 20 years younger than those with invasive adenocarcinoma. 8 14 16 The natural history of L-CGIN is poorly documented. Only a few studies have compared the mean age of patients with glandular dysplasia (L-CIGN) and adenocarcinoma in situ (H-CGIN) in the same series. 5 8 9 30 These studies have reported a diVerence of only one to three years in the mean age between low and high grade lesions. In this study we found a diVerence of four years. If the natural history follows this pattern, there seems to be a short clinical window for detecting early glandular lesions.
Whether all glandular precursor lesions eventually progress to invasive disease remains uncertain. In our study, the ratio of "precursor" lesions to invasive adenocarcinomas diagnosed in the same study period is nearly equal-that is, 1.12:1 (65:56). This is unlike its squamous counterpart in which CIN3 lesions far outnumber invasive disease by a ratio of approximately 15:1 (Al-Nafussi A, unpublished data). The other interesting finding was the ratio of microinvasive adenocarcinoma to H-CGIN. We found that 21% of the latter contained foci of early invasion. This is much less than reported by Teshima et al, 25 who showed that 22 of 30 cases of adenocarcinoma in situ (73%) had features of early invasion. It is also of interest that in our study the mean age of women with both high grade and microinvasive adenocarcinoma was the same (43 years), while in Teshima's series there was a diVerence of six years. This diVerence in age groups between the two studies might explain the variation in our findings. From these observations, it appears that high grade CGIN is almost certainly a precursor of invasive adenocarcinoma, in view of the high percentage of early invasion coexisting with high grade lesions.
As to the natural history of L-CGIN, it is not clear whether all or some would eventually progress to high grade or invasive adenocarcinoma. From our observation it appears that such lesions may progress to H-CGIN or even to invasive disease-first, because of the The 95% confidence intervals for percentages are given in parentheses.
presence of low grade lesions in association with high grade lesions and microinvasive adenocarcinoma; second, because of the age diVerence of four years between the low and the high grade lesions; and third, because the ratio between L-CGIN and H-CGIN in our study was 0.96:1 (27:38). If low or high grade lesions often regress, one would expect to see them more often in the many cervical biopsies we encounter every day, though it is possible that some low grade lesions may be missed or be misinterpreted as benign non-neoplastic processes such as tuboendometrial metaplasia or mesonephric duct remnants. 34 In support of progression, Umezaki et al showed that there was expression of epithelium specific antigen (ESA; a useful marker of endocervical glandular dysplasia and related lesions with malignant transformation) in over half the endocervical dysplasia specimens they examined. 35 This rate of expression was similar to that seen in most of the cervical adenocarcinomas they studied. 35 There is currently no standard treatment for precursor glandular lesions. Whether cervical conisation alone is therapeutic is still controversial. One reason for this controversy is the presence of residual disease in hysterectomy specimens, following what appeared to be complete loop or cone excisions of H-CGIN (adenocarcinoma in situ). 32 33 36-47 The incidence of residual H-CGIN (adenocarcinoma in situ) in hysterectomy specimens following cone excisions with involved margins has been calculated to be approximately 60%. 33 Furthermore, occult invasive carcinoma has also been detected in such cases. 33 36-47 In our study, residual disease was found in 43%, 50%, and 33% of hysterectomies for L-CGIN, H-CGIN, and microinvasive adenocarcinoma, respectively. This high rate of residual disease occurred particularly in those cases with positive margins on previous loop excisions. Residual disease was similarly seen in one of our cases of H-CGIN with clear margins. This is not surprising considering the frequent multifocal nature of CGIN detected in this study, and the size of the loop excision procedure compared with cold knife conisation. It has been shown that conisation is associated with a 33% rate of positive margins compared with 50% for large loop excision of the transformation zone (LLETZ). 32 Similarly the disease recurrence rate is higher in patients treated with LLETZ (29%) than in those treated by cone excision (6%). 32 This is unlike CIN lesions, in which the loop excision procedure appears to be as eVective as conisation. 46 Furthermore, Denehy et al have found that negative endocervical curettings and uninvolved cone margins in patients with cervical adenocarcinoma in situ did not exclude the presence of residual endocervical glandular disease in subsequent surgical specimens. 47 They have suggested that conservative management and subsequent surveillance of adenocarcinoma in situ should be undertaken with caution. 47 This is in contrast to a recent report by Houghton et al, 48 who studied 19 cases of adenocarcinoma in situ of the cervix that were initially treated by diathermy loop excision. They found no residual diseases in five of their cases in which further surgery was performed. They concluded that excision margin status does not appear to be predictive of residual disease.
The cytological features of glandular neoplasia have been refined recently. 6 11 15 30 49-52 In our study, in those women who had smears before diagnosis, 59%, 70%, 100%, and 32% of low grade CGIN, high grade CGIN, microinvasive adenocarcinoma, and frankly invasive adenocarcinoma, respectively, were predicted by cytology. Luesley et al reported that 71% of their cases had at least one cervical smear suggesting glandular abnormality in the preceding 12 months. 9 Widrich et al reported that 19 of 45 cases of adenocarcinoma in situ (42%) had glandular abnormality on smear test, 30 while Casper et al reported that only 23% of low grade CGIN were screen detected. 21 As in previous reports, 5 32 a significant proportion of our cases (30% of L-CGIN, 24% of H-CGIN, and 7% of invasive adenocarcinoma) were discovered incidentally at loop excision for CIN or at hysterectomy for benign lesions. Squamous abnormality on cervical smears may often overshadow coexisting glandular lesions. 8 9 30 31 The presence of mixed squamous and glandular lesions occurs in 49% to 69% of cases. 9 21 48 49 In our study coexisting CIN was found in 55% of L-CGIN cases, 47% of H-CGIN cases, 40% of microinvasive adenocarcinomas, and 11% of invasive adenocarcinomas. This is in keeping with the theory of a unicellular origin and common aetiological factors for both lesions. [53] [54] [55] [56] [57] Whatever the cause of this association, it seems to enable a significant number of cases of CIGN to be discovered that would otherwise have presented as invasive disease.
The cases in our study span 1990 to 1995, limiting full five year follow up on later cases. We regarded a successful outcome as those cases with multiple negative smears following treatment (four to nine negative smears). In the great majority of our cases (all the L-CGIN cases, 95% of the H-CGIN cases, and all the microinvasive adenocarcinomas) there was no glandular abnormality on follow up. However, squamous dysplasia/dyskaryosis was detected in 15% and 2% of treated low grade and high grade CGIN cases, respectively.
Microinvasive adenocarcinomas in this study behaved like H-CGIN. This in keeping with previous reports. 22 24 Eight of our microinvasive adenocarcinomas (80%) were stage 1A1 (less than 3 mm in depth). This is slightly higher than the figures of 50% and 55% reported by Teshima et al and Ostor et al, 23 25 but the numbers are small.
CONCLUSIONS
The results of this study support the view that there is a progression of L-CGIN and H-CGIN to early stromal invasion and eventually to frankly invasive disease. The evidence for this is the progressive increase in mean age of patients from "precursor lesions" to invasive adenocarcinoma, the high incidence of microinvasive adenocarcinoma in association with H-CGIN, and the near equal ratio between non-invasive and invasive disease. This progression perhaps takes place within 10 years or less. In the management of precursor lesions we strongly recommend a large loop excision with free margins in patients who are not treated by hysterectomy. Finally we endorse the use of the term "microinvasive adenocarcinoma" as a distinct entity, as it has an excellent prognosis if treated by hysterectomy.
